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A Change in the Conformation of Prions
Accompanies the Emergence of a New Prion Strain
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result of exposure to BSE prions (Anderson et al., 1996;
Bruce et al., 1997; Collinge et al., 1996; Hill et al., 1997;Summary
Lasme´zas et al., 1996; Scott et al., 1999; Wadsworth
et al., 1999). The human disease, termed new variantTo investigate the role of the pathogenic prion protein
Creutzfeldt-Jakob disease (nvCJD), displays a disease(PrPSc) in controlling susceptibility to foreign prions,
phenotype that is markedly different from previouslytwo Syrian hamster (SHa) prion strains, Sc237 and
identified forms of CJD (Ironside, 1997; Will et al., 1996).DY, were transmitted to transgenic mice expressing
The transmission of bovine prions to humans contrastschimeric SHa/mouse PrP genes, Tg(MH2M). First pas-
with that of scrapie, the prion disease of sheep andsage of SHa(Sc237) prions exhibited prolonged incu-
goats, to which humans have had centuries of exposurebation times, diagnostic of a species barrier. PrPSc
and show no evidence of transmission (Cousens et al.,of the new MH2M(Sc237) strain possessed different
1990; Malmgren et al., 1979). These apparent differencesstructural properties from those of SHa(Sc237), as
in the transmissibilities of bovine and sheep prions todemonstrated by relative conformational stability
humans have highlighted the need to better understandmeasurements. This change was accompanied by a
the factors that govern interspecies transmission of pri-disease phenotype different from the SHa(Sc237)
ons and the emergence of prion strains with new diseasestrain. Conversely, transmission of SHa(DY) prions to
phenotypes.Tg(MH2M) mice showed no species barrier, and the
Transmission of prion diseases between hosts of theMH2M(DY) strain retained the conformational and dis-
same mammalian species is typically highly efficientease-specific properties of SHa(DY). These results
with a uniform and consistent incubation period. In con-suggest a causal relationship between species barri-
trast, prion transmission between animals of differenters, changes in PrPSc conformation, and the emer-
species often fails to cause disease and, when success-gence of new prion strains.
ful, is characterized frequently by a relatively prolonged
incubation during the first passage. Upon serial homolo-Introduction
gous transmission in the new species, the incubation
time shortens, usually within a single passage, and the
Prion diseases are infectious fatal degenerative disor-
new incubation period is maintained during subsequent
ders of the central nervous system (CNS). The funda- passages. This comparative resistance to infection, as
mental event underlying these diseases is the accumula- seen in the first passage to a new species, has been
tion of an insoluble isoform (PrPSc) of the host-encoded termed as the “species barrier” (Pattison, 1965).
prion protein (PrPC) (Prusiner, 1999). Many lines of evi- It has been recognized for many years that passage
dence argue that PrPSc is the sole component of the of prions through animals of different species may lead
infectious pathogen (Prusiner, 1982). Spectroscopic to the establishment of prion strains that are different
studies suggest that PrPC is converted into PrPSc through from the ancestral ones (Dickinson, 1976; Kimberlin,
a process whereby some of its structure is converted 1979; Pattison, 1966; Ridley and Baker, 1996). In fact,
into  sheet (Caughey et al., 1991; Gasset et al., 1993; the experimental use of different species for prion prop-
Pan et al., 1993; Pergami et al., 1996; Safar et al., 1993). agation was largely responsible for the recognition that
This structural transition is accompanied by profound multiple prion strains can exist in genetically identical
changes in the physicochemical properties of PrP. PrPC hosts and led to assertions that the scrapie “agent”
is readily soluble in nondenaturing detergents and is must therefore possess an independent genome (Bruce
digested rapidly by proteases. In contrast, PrPSc is insol- and Dickinson, 1987; Bruce and Fraser, 1991).
uble in such detergents and is resistant to proteolysis When transgenic (Tg) mice were constructed express-
ing Syrian hamster (SHa) PrP, they were found to be
highly susceptible to SHa prion strain Sc237, in sharp6 Correspondence: ind@itsa.ucsf.edu
7 Present address: School of Medicine, Fukuoka University, Japan. contrast to control mice expressing mouse PrP (Scott
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Table 1. Incubation Times for Sc237 and DY Prions Passaged in Syrian Hamsters (SHa), Tg(MH2M) Mice, or Tg(SHa) Mice
Inoculuma Host n/n0b Days  SEMc
SHa(Sc237) SHa 66/68 75  0.3
SHa(Sc237) Tg(MoPrP)4053 1/15 536
SHa(Sc237) Tg(MH2M)229/Prnp0/0 41/41 83  1.6
MH2M(Sc237) Tg(MH2M)229/Prnp0/0 40/40 50  0.1
MH2M(Sc237) SHa 29/30 113  1.8
MH2M(MH2M(Sc237)) SHa 17/20 133  2.2
SHa(DY) SHa 41/41 165  1.0
SHa(DY) Tg(MH2M)229/Prnp0/0 28/29 70  1.0
MH2M(DY) Tg(MH2M)229/Prnp0/0 28/28 76  1.0
MH2M(DY) SHa 26/26 176  2.0
MH2M(MH2M(DY)) SHa 20/20 153  2.0
SHa(Sc237) Tg(SHa)3922/Prnp0/0 17/17 44  1.1
TgSHa(Sc237) Tg(SHa)3922/Prnp0/0 20/20 53  0.5
TgSHa(Sc237) SHa 20/20 80  0.5
a Inoculum was a 1% (w:v) crude brain homogenate of prion-infected animals. See Experimental Procedures for passage history.
b n, number of animals developing clinical signs of prion disease; n0, total number of animals inoculated. Animals dying atypically following
inoculation were excluded (Prusiner and McKinley, 1987).
c Mean incubation period in days  standard error of the mean (SEM).
et al., 1989). From these studies and many others (Prusi- SHa(Sc237) strain displayed similar relative conforma-
tional stabilities. These findings suggest that: (1) a factorner et al., 1990; Scott et al., 1997; Telling et al., 1995),
it became clear that the species barrier depends on the other than sequence homology, which we believe to be
the conformation of PrPSc, directly affects the transmis-homology of the donor and the host PrP genes. Although
studies with Tg mice have established the significance sion efficiency between species, (2) inefficient transmis-
sion of prions between species with distinct PrP genesof the amino acid sequence of PrP, less clear is whether
the conformational state of PrPSc influences the ease of leads to the emergence of new prion strains with confor-
mations that are different from the original, and (3) thistransmission, and if it does, how it relates to observed
changes in disease properties (Ridley and Baker, 1996). conformational change coincides with new disease phe-
notypes in infected hosts.To investigate these possibilities, two SHa prion strains,
Sc237 and DY, that represent distinct conformers of
PrPSc with the same amino acid sequence (Peretz et al., Results
2001) were transmitted to Tg mice expressing a chimeric
mouse/hamster PrP gene termed MH2M (Scott et al., Transmission of SHa(Sc237) Prions
to Tg(MH2M) Mice1993). Following transmission to the Tg(MH2M) mice, we
compared incubation time to disease and neuropatho- Tg(MH2M) mice expressing chimeric mouse/SHa PrPC
are susceptible to the SHa(Sc237) prion strain (Scott etlogical characteristics of the original and Tg(MH2M)-
passaged strains, and we correlated these strain proper- al., 1993), with an incubation time to illness of 83 days
(Table 1). Brain extracts of Tg(MH2M) mice containingties with changes in the conformation of PrPSc for each
strain using a relative conformational stability assay (Pe- chimeric MH2M(Sc237) prions were passaged in
Tg(MH2M) mice (Table 1), resulting in an incubation pe-retz et al., 2001). As a control for these transmissions to
Tg(MH2M) mice, we also inoculated Tg mice expressing riod of 50 days, a decrease of 33 days from the original
SHa(Sc237) passage into the same line of mice. Thisthe homologous SHaPrP gene, designated Tg(SHa) mice.
In the experiments reported here, we show that trans- decrease in incubation period after the first passage is
an essential characteristic of the species barrier effectmission of one of these prion strains, SHa(Sc237), to
Tg(MH2M) mice was characterized by a species barrier (Pattison, 1965). The prions formed after the second
passage, i.e., Syrian hamster → Tg(MH2M) mice →and led to the subsequent isolation of MH2M(Sc237)
prions that had a relative conformational stability that Tg(MH2M) mice, were denoted MH2M(MH2M(Sc237)).
was markedly different from the parental strain. The
conformational change in PrPSc was mirrored by a SHa(Sc237) and MH2M(Sc237) Prions Differ
in Conformational Stabilitychange in the phenotypic properties of the new strain,
MH2M(Sc237). In contrast, the other strain, SHa(DY), When analyzed by proteinase K (PK) digestion and Western
blots, high levels of SHa(Sc237) and MH2M(Sc237) PrPScwhen passaged to the same line of Tg(MH2M) mice,
resulted in neither a species barrier nor any apparent were detected in SHa and Tg(MH2M) mice, respectively
(Figure 1). SHa(Sc237) and MH2M(Sc237) PrPSc appearchange in strain properties. MH2M(DY) PrPSc had a rela-
tive conformational stability similar to that of SHa(DY) to have similar profiles of glycosylation (Figure 1D), and
removal of the two N-linked glycans yielded fragmentsPrPSc and produced a similar disease phenotype in
Tg(MH2M) mice. As expected from previous studies with an apparent molecular weight (Mr) of 21 kDa (Figure
1C). To study further the properties of PrPSc, conforma-(Prusiner et al., 1990; Scott et al., 1989), SHa(Sc237)
prions caused disease in Tg(SHa) mice with no evidence tional stability measurements were performed following
denaturation with increasing concentrations of guani-of any species barrier, and the TgSHa(Sc237) PrPSc de-
rived from this passage and PrPSc from the original dine hydrochloride (GdnHCl), followed by PK digestion
Conformational Changes of Prion Proteins
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Figure 1. Protease Digestion and PrP Patterns of Sc237 and DY Prion Strains
(A and B) 10 g of brain homogenates (1 mg/ml) and (C) 1 g of P2 fraction proteins (1 mg/ml) were loaded on SDS/PAGE that were either
untreated (A), treated with 20 g/ml of proteinase K for 1 hr at 37C (B), or with 10 /ml of PNGase F for 12 hr at 37C (C). Homogenates were
prepared from Syrian hamsters (SHa) or Tg(MH2M) mice inoculated with the following prion strains: (lanes 1 and 4) none; (lanes 2 and 5)
SHa(Sc237); (lanes 3 and 6) SHa(DY); (lane 7) MH2M(Sc237); (lane 8) MH2M(DY). PrP was analyzed following Western blotting and detection
with anti-PrP mAb 3F4 (Kascsak et al., 1987). (D) Densitometry analysis of the three distinct bands shown in (B) representing di-glycosylated
(band with the highest molecular mass), mono-glycosylated, and un-glycosylated (band with the lowest molecular mass) PrPSc, given as
percentages of total PrPSc. The results are the mean with the standard deviation (SD) calculated from two experiments.
and ELISA detection of residual PrPSc using a chimeric, Syrian hamsters produced an incubation period of 75
days. When MH2M(Sc237) prions, derived by a singlehumanized version (HuM) of the recombinant antibody
passage in Tg(MH2M) mice, were transmitted to Syrianfragment (Fab) D18 (Peretz et al., 2001).
hamsters, the incubation period was significantly longerAlthough denaturation of both SHa(Sc237) and
at 113 days (Table 1). After a second homologousMH2M(Sc237) PrPSc exhibited sigmoidal transitions, sub-
passage in Tg(MH2M) mice, the MH2M(MH2M(Sc237))stantial differences in the stabilities of the two proteins
prions yielded an even longer incubation time of 133were observed (Figure 2). The concentration of GdnHCl
days when reintroduced into Syrian hamsters (Table 1).at the midpoints of these transitions ([GdnHCl1/2]) for
Transmission of SHa(Sc237) to Syrian hamsters pro-SHa(Sc237) and MH2M(Sc237) were 1.8 M and 1.1 M,
duced numerous small subependymal PrP amyloidrespectively (Figures 2A and 2B). Subsequent passage
plaques over the surface of the hippocampus (Bendheimof MH2M(Sc237) in Tg(MH2M) mice did not alter the
et al., 1984) (Figure 3A). In addition, delicate granularstability of PrPSc (Figure 2C). The [GdnHCl]1/2 values were
deposits of PrPSc were found in the white and gray mat-relatively independent of protein concentration, as
ter. Transmission of SHa(Sc237) prions to Tg(MH2M)demonstrated by normalizing the absorbancies (Figures
mice, however, produced a profoundly different PrP de-2D–2F). These data argue that a single passage of
position phenotype, which was maintained on serialSHa(Sc237) prions in Tg(MH2M) mice produced a new
passaging in this Tg line (Figures 3B, 6C, and 6D). Theconformer of MH2M(Sc237) PrPSc that is markedly differ-
resulting subependymal plaques consisted of a centralent from the Sc237 PrPSc that propagates in Syrian ham-
core PrP immunopositive amyloid, 10–15 times largersters (Table 2).
than the individual plaques in Syrian hamsters, and a
surrounding halo of smaller satellite plaques (Figure 6D).
Different Disease Phenotypes Caused by These amyloid plaques are characteristic of those found
SHa(Sc237) and MH2M(Sc237) Prions in the ataxic form of Gerstmann-Stra¨ussler-Scheinker
The substantial difference in the conformational stability disease (GSS) and are commonly designated as GSS-
of SHa(Sc237) PrPSc compared to that of MH2M(Sc237) type plaques (DeArmond and Ironside, 1999). In addi-
PrPSc was reflected in contrasting biological properties tion, multiple deposits of PrPSc were found throughout
the gray and white matter. Together with incubationof the two strains. SHa(Sc237) prions transmitted to
Neuron
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Figure 2. Denaturation Transitions of Sc237 PrPSc
P2 fractions were prepared from brains of: (A and D) Syrian hamsters (n  10) inoculated with SHa(Sc237) prions; (B and E) Tg(MH2M) mice
(n  5) inoculated with SHa(Sc237) prions; and (C and F) Tg(MH2M) mice (n  20) inoculated with MH2M(Sc237) prions and treated with
increasing concentrations of GdnHCl. Following 1 hr of incubation, the samples were diluted, treated with proteinase K for 1 hr at 37C, and
precipitated with methanol/chloroform. (A–C) ELISA wells were coated with 50 l of 1 (open triangles), 2.5 (closed triangles), 5 (open
circles), and 10 g/ml (closed circles) of denatured proteins. PrP was detected with Fab HuM-D18 (0.25 g/ml), and absorbency was read
after 60 min of color development. The sigmoidal patterns of PrP were plotted with a four-parameter algorithm using a nonlinear least-square
fit and correlation coefficient greater than 0.97. Each data point shown is the mean of duplicate readings, and error bars represent SEM. (D–F)
Apparent fractional appearance (Fapp) was calculated for each ELISA OD mean value, and the sigmoidal patterns were plotted as in (A)–(C).
times to disease and PrPSc structural data, the neuro- MH2M(DY) prions were passaged in Tg(MH2M) mice,
the incubation period was 76 days. Thus, Tg(MH2M)pathological differences argue that transmission of
SHa(Sc237) prions to Tg(MH2M) mice led to the forma- mice were equally permissive to SHa(DY) and MH2M(DY)
prions.tion of MH2M(Sc237) prions with properties that are
dramatically different from those of the original strain.
Similar Conformational Properties of SHa(DY)
and MH2M(DY) PrPScSHa(DY) Prions Infect Tg(MH2M) Mice
without a Species Barrier Aliquots of brain homogenates from inoculated Syrian
hamsters and Tg(MH2M) mice were subjected to limitedInoculation of Tg(MH2M) mice with SHa(DY) prions
produced an incubation time of 70 days (Table 1). proteolytic digestion and analyzed by Western blots,
demonstrating low levels of SHa(DY) and MH2M(DY)When brain extracts from Tg(MH2M) mice containing
Table 2. Properties of Sc237 and DY PrPSc in SHa and Tg Mice
Priona Host Mrb [GdnHCl]1/2  SDc
SHa(Sc237) SHa 21 1.8  0.16 (6)
TgSHa(Sc237) Tg(SHa) 21 1.7  0.10 (5)
MH2M(Sc237) Tg(MH2M) 21 1.1  0.09 (5)
MH2M(MH2M(Sc237)) Tg(MH2M) 21 0.96  0.14 (12)
SHa(DY) SHa 19 0.98  0.13 (6)
MH2M(DY) Tg(MH2M) 19 1.1  0.06 (8)
MH2M(MH2M(DY)) Tg(MH2M) 19 1.0  0.09 (9)
a Nomenclature of prion strains.
b Apparent molecular weight (Mr) of the deglycosylated protease-resistant fragment of PrPSc.
c ELISA denaturation transitions were performed using monoclonal antibody fragment (Fab) HuM-D18 (0.25 g/ml), and [GdnHCl]1/2 values
were interpolated with a sigmoid algorithm using a nonlinear least-square fit. The results are the mean with the standard deviation (SD)
calculated from the number of denaturation curves given in parentheses.
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MH2M(DY) and MH2M(MH2M(DY)) prions into Syrian
hamsters produced similar incubation periods of 176
and 153 days, respectively (Table 1). When transmitted
to Tg(MH2M) mice, SHa(DY) and MH2M(DY) prions pro-
duced similar incubation periods, of 70 and 76 days,
respectively.
Consistent with the analogous conformational stabili-
ties and incubation times we observed for SHa(DY) and
MH2M(DY) prions, patterns of PrPSc deposition in the
animals infected with those strains were also similar.
There was no apparent change in PrPSc deposition when
SHa(DY) prions were transmitted to Tg(MH2M) mice
(Figures 3C and 3D). PrPSc deposition for DY prions was
primarily perivascular in both Syrian hamsters and
Tg(MH2M) mice; granular deposits were present in virtu-
ally all white matter tracts and were particularly promi-
nent in the cerebellar white matter (data not shown).
Transmission of SHa(Sc237) Prions to Tg(SHa) Mice
and Biochemical Similarities of SHa(Sc237)
and TgSHa(Sc237) PrPSc
In view of the differences between transmission of
SHa(Sc237) and SHa(DY) prions to Tg(MH2M) mice, we
inoculated Tg(SHa) mice, which express homologous
Syrian hamster PrPC (Scott et al., 1989). Following inocu-
lation with SHa(Sc237) prions, these mice yielded an
incubation time of 45 days (Table 1). When brain ex-
tracts from Tg(SHa) mice containing TgSHa(Sc237) pri-
Figure 3. The PrPSc Deposition Phenotypes for Sc237 and for DY ons were repassaged in Tg(SHa) mice, the incubationPrions in Syrian Hamsters and in Tg(MH2M) Mice Are Significantly
period was only slightly different at 53 days (Table 1).Different
This result is consistent with previous findings thatTransmission of SHa(Sc237) prions to Tg(MH2M) mice significantly
SHa(Sc237) prions do not encounter a species barrieraltered its PrPSc deposition phenotype, but similar transmission of
when transmitted to Tg mice expressing SHa PrPC (Pru-SHa(DY) prions had no effect on PrP deposition.
(A) Syrian hamsters inoculated with SHa(Sc237) prions. siner et al., 1990) and contrasts with the dramatic change
(B) Tg(MH2M)229 mice inoculated with MH2M(Sc237) prions ob- in incubation period observed with the Sc237 strain in
tained from a single passage of SHa(Sc237) prions in Tg(MH2M)229. Tg mice expressing MH2M PrPC (Table 1).
(C) Syrian hamsters inoculated with SHa(DY) prions.
The slightly shorter incubation period observed when(D) Tg(MH2M)229 mice inoculated with MH2M(DY) obtained from a
Tg(SHa) mice were inoculated with SHa(Sc237) as com-single passage of SHa(DY) prions in Tg(MH2M)229. Bar in (A) is 50
pared to TgSHa(Sc237) prions (Table 1) was probablym and also applies to (B) and (C). Hp, gray matter of the hippocam-
pus; cc, white matter of the corpus callosum. Bar in (D) is 25 m caused by a difference in the titer of Sc237 prions in the
(the magnification in this micrograph was increased to better visual- brains of infected hamsters and Tg(SHa) mice. We infer
ize the perivascular PrP deposits). this from a Western blot comparison of total PrP in
Tg(SHa) mice and hamsters inoculated with SHa(Sc237)
or TgSHa(Sc237) prions. Whereas strong signals were
PrPSc (Figure 1). The PrPSc of SHa(DY) and MH2M(DY) obtained in Syrian hamster brains infected with
consisted of similar glycosylated and unglycosylated SHa(Sc237) (Figure 5A, lanes 1 and 4), levels of PrP in
fragments (Figure 1D). After PNGase F digestion, the degly- infected Tg(SHa) mice appeared to be only slightly
cosylated PrPSc had an Mr of 19 kDa (Figures 1B and 1C). higher than those present in uninoculated control
Conformational stability measurements showed that Tg(SHa) mice (Figure 5A, lanes 5, 7, and 9), suggesting
SHa(DY), MH2M(DY), and MH2M(MH2M(DY)) PrPSc that the terminal concentration of PrPSc (and by infer-
displayed similar denaturation curves, with mean ence, infectious Sc237 prions) in the brains of prion-
[GdnHCl]1/2 values of 1.0, 1.1, and 1.0 M, respectively infected Tg(SHa) mice is significantly lower than in ham-
(Figure 4, Table 2).
sters (Figure 5A, compare lane 4 with lanes 8 and 10).
Limited proteolysis followed by Western blotting after
removal of the N-linked glycans from TgSHa(Sc237)Similar Disease Phenotypes from SHa(DY)
PrPSc yielded a fragment of 21 kDa, which was indistin-and MH2M(DY) Prions
guishable from that of SHa(Sc237) PrPSc (Figure 5B).Inoculated animals showed similar incubation times for
Conformational stability measurements confirmed thatSHa(DY) and MH2M(DY) prions. Consistent with previ-
SHa(Sc237) and TgSHa(Sc237) PrPSc display similar de-ous reports, transmission of SHa(DY) prions to Syrian
naturation profiles, with mean [GdnHCl]1/2 values of 1.8hamsters resulted in an incubation period of 167 days
(Table 1) (Bessen and Marsh, 1994). Inoculation of and 1.7 M, respectively (Figure 5C, Table 2).
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Figure 4. Denaturation Transitions of DY Prion Strains
P2 fractions prepared from brains of: (A) Syrian hamsters (n  10) inoculated with SHa(DY) prions; (B) Tg(MH2M) mice (n  4) inoculated with
SHa(DY) prions; and (C) Tg(MH2M) mice (n  20) inoculated with MH2M(DY) prions. Proteins were denatured, PK digested, and detected in
ELISA. Fapp values were calculated and sigmoidal curves were plotted as described in Figure 2, except that absorbency was read after 90
min of color development.
Similar Disease Phenotypes from SHa(Sc237) were found in the white and gray matter in inoculated
Syrian hamsters, but absent in the same locations inand TgSHa(Sc237) Prions
We also found that the hamster- and Tg(SHa) mouse- inoculated Tg(SHa) mice.
passaged prions produced an identical disease pheno-
type. In Syrian hamsters, inoculation of TgSHa(Sc237)
prions resulted in an incubation period of 80 days, similar Discussion
to the 75 day period from SHa(Sc237) prions (Table 1).
Additionally, PrP amyloid deposition in Syrian hamsters Our findings provide biochemical insights into a molecu-
lar mechanism that leads to the emergence of new prionand Tg(SHa) mice inoculated with Sc237 prions was
similar, with the formation of subependymal PrP amyloid strains. We present evidence that the misfolded state
of the pathogenic prion protein is an important determi-plaques over the surface of the hippocampus (Figures
3A and 6A), although those in Tg(SHa) mice tended to be nant of the disease-causing properties of prion strains.
We further show that the typical change in incubationtwo to three times larger than those in Syrian hamsters
(compare Figures 3A and 6A) (Prusiner et al., 1990). period diagnostic of a species barrier is also indicative
of the accumulation of a new conformer of PrPSc andThis pattern of deposition was maintained upon serial
passages of Sc237 prions in Tg(SHa) mice (Figure 6B). consequently the emergence of a new prion strain. Our
results demonstrate a correlation between the confor-We observed only one major variation in PrPSc deposition
between Syrian hamsters and Tg(SHa) mice inoculated mational state of PrPSc and prion disease phenotype,
supporting the hypothesis that biological properties ofwith Sc237 prions; delicate granular deposits of PrPSc
Figure 5. Protease Digestion, PrP Patterns, and Denaturation Curves of TgSHa(Sc237) Prions
(A) 10 g of brain homogenates (1 mg/ml) was loaded on SDS/PAGE that was either untreated (odd numbers) or treated with 20 g/ml of
proteinase K for 1 hr at 37C (even numbers). Homogenates were prepared from Syrian hamsters (lanes 1–4) and Tg(SHa) mice (lanes 5–10)
inoculated with the following prion strains: none (lanes 1, 2, 5, and 6); SHa(Sc237) (lanes 3, 4, 7, and 8); TgSHa(Sc237) (lanes 9 and 10).
(B) 1 g of P2 fraction proteins (1 mg/ml) was loaded on SDS/PAGE treated with 20 g/ml of proteinase K for 1 hr at 37C, followed by 10
u/ml PNGase F for 12 hr at 37C. PrP was analyzed following Western blotting and detection with anti-PrP mAb 3F4 (Kascsak et al., 1987).
(C) P2 fractions prepared from brains of Tg(SHa) mice (n 10) inoculated with SHa(Sc237) prions were denatured and PK digested. TgSHa(Sc237)
PrPSc was detected in ELISA as described in Figure 2, except that absorbency was read after 90–120 min of color development.
Conformational Changes of Prion Proteins
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Furthermore, the patterns of deposition of PrPSc ob-
served in the brain were strikingly different, with small
amyloid plaques over the hippocampus in Tg(SHa) mice
and hamsters infected with SHa(Sc237) prions and much
larger, GSS-type plaques in Tg(MH2M) mice infected
with MH2M(Sc237) prions (compare Figures 3A and 6D).
These observations argue for a correlation between the
species barrier and new prion properties and suggest
that transmission of this isolate to Tg(MH2M) mice leads
to selection of a new prion strain.
Factors Influencing the Species Barrier
and Emergence of New Prion Strains
It has been well documented that the transmission of
prion strains from one species to another can sometimes
lead to the isolation of strains with properties that differ
from those of the ancestral strains (Dickinson, 1976;
Kimberlin et al., 1989). In the past, such changes were
attributed to a high mutation rate in the parental strain
and were interpreted as evidence for a nucleic acid
genome within the prion particle, despite the lack of a
candidate molecule (Bruce and Dickinson, 1987; Kim-
berlin et al., 1989).
Sequence homology between the PrPC of the host
and PrPSc of the inoculum is a major determinant in
controlling susceptibility to prion disease. It is generally
assumed, therefore, that humans benefit by some de-
gree of protection from exposure to prions of other spe-
cies. However, sequence homology cannot completely
Figure 6. The Size and Structure of Sc237-Induced PrP Amyloid explain the species barrier effect (Bruce et al., 1994). In
Plaques in Tg(SHa) and Tg(MH2M) Mice
our studies, we observed that a single Tg(MH2M) mouse
(A) Tg(SHa) inoculated with SHa(Sc237) prions.
host “species” exhibited markedly different levels of(B) Tg(SHa) inoculated with TgSHa(Sc237) prions obtained from a
susceptibility to two prion strains sharing the same SHasingle passage of SHa(Sc237) prions in Tg(SHa).
amino acid sequence. Thus, limited host sequence ho-(C) Tg(MH2M)229 mice inoculated with SHa(Sc237) prions.
(D) Tg(MH2M)229 mice inoculated with MH2M(Sc237) obtained from mology, as seen in this model system, has a variable
a single passage of SHa(Sc237) prions in Tg(MH2M)229. cc, corpus effect on interspecies prion transmission, and the de-
callosum; nc, neocortex; p, pyramidal cell layer of the CA1 region gree of resistance therefore must depend upon both the
of the hippocampus; v, lateral ventricle. Freezing artifact can be
strain of prion as well as the sequence of PrP. It is wellseen particularly in (B) and (C). The bar in (A) is 50 m and applies
established that a given species can sustain distinctto all of the photomicrographs.
prion strains, demonstrating that an informational vari-
able independent of the amino acid sequence of PrPSc
exists. Structural studies on distinct hamster prionprion strains are enciphered by the misfolded state of
strains make it highly likely that all or most of this infor-the prion protein.
mational diversity is contained within the conformation
of PrPSc (Bessen and Marsh, 1992, 1994; Peretz et al.,Correlation between the Species Barrier, Changes
2001; Safar et al., 1998; Telling et al., 1996).in PrPSc Conformation, and Emergence
of New Prion Strains
In the present study, we found that in transmissions that A Molecular Basis for the Species Barrier
The differences we observed in interspecies transmissi-encountered a species barrier, the resultant prion strain
displayed biochemical and neuropathological proper- bility might be attributed to molecular differences be-
tween the strains. SHa(Sc237) and SHa(DY) strains seemties that differed from those of the original inoculum.
However, some transmissions between hosts with dif- to maintain the same glycoform ratios, so observed dif-
ferences cannot be explained by the glycosylation stateferent PrP sequences could be accomplished without
evidence of a species barrier, and in these cases, the of PrPSc. Furthermore, there is currently no evidence for
a species-specific ligand, such as a nucleic acid.original prion strain characteristics were retained.
Comparisons of prion strains were made using both At the molecular level, the only known variable that
distinguishes SHa(DY) from SHa(Sc237) strains seemsqualitative and quantitative methods: by assessing incu-
bation period, observing the neuropathology produced to be the conformation of the PrPSc molecule. These
differences are apparent through alterations in suscepti-in the animal, and by measurements of PrPSc relative
conformational stability. SHa(Sc237) and MH2M(Sc237) bility to protease digestion (Bessen and Marsh, 1992),
N-terminal cleavage sites by proteases (Bessen andprions produced different incubation periods in Syrian
hamsters (75 and 113 days, respectively) and displayed Marsh, 1994; Telling et al., 1996),  sheet secondary
structure (Caughey et al., 1998), epitope exposure atdistinct [GdnHCl]1/2 values (1.8 and 1.1 M, respectively).
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residues 109–112 (Safar et al., 1998), and conformational was not calculated. Instead, we chose to express the
[GdnHCl]1/2 as a measure for the relative conformationalstability (Peretz et al., 2001). We conclude that the con-
formational state of PrPSc can modulate the interspecies stability of PrPSc (Peretz et al., 2001). When we utilized
this technique to study strains that propagate in Syriantransmissibility of prions and therefore the presence or
absence of a species barrier. hamsters, we found that strains that cause disease with
comparable characteristics also exhibit similar confor-
mational properties of PrPSc in seven out of eight strains.Inferring Conformational States of PrPSc
Given the ability of this assay to accurately defineIf the “protein-only” hypothesis is accepted, prion
pathological conformers that accompany disease prop-strains in animals of the same species must maintain
erties, we applied this approach to prion strains in thisdistinct structures of PrPSc. A major challenge to prove
study. We found that PrPSc of two isolates, SHa(Sc237)this hypothesis is to demonstrate such linkage. Since
and TgSHa(Sc237), which produced the same diseasethe insolubility of PrPSc is incompatible with current NMR
phenotype in inoculated animals, also display similaror X-ray diffraction techniques, the molecular transfor-
[GdnHCl]1/2 values, of 1.8 M and 1.7 M, respectively,mations that PrPSc may undergo to yield strain specificity
whereas PrPSc of MH2M(Sc237), which caused a diseaseare not well understood. While in some cases, distinct
with a different phenotypic presentation, possessed aPrPSc types can be distinguished by Western blotting
significantly lower [GdnHCl]1/2 value, of 1.1 M. This directfollowing protease digestion (Collinge et al., 1996; Parchi
link between conformation and strain properties waset al., 1996), it is not always possible to associate a
reinforced by the comparison of the DY strains; SHa(DY)specific pattern with a single distinct strain. For exam-
and MH2M(DY) that produced virtually identical neuro-ple, it has been reported that some mouse prion strains
pathogenicity also manifested the same PrPSc denatur-(Somerville et al., 1997) and the prions responsible for
ation curves, with [GdnHCl]1/2 values of 1.0 M. Thesecausing fatal familial insomnia in humans (Telling et al.,
observations suggest that the DY prion strain can be1996) showed a “BSE-like” glycoform pattern (Collinge
maintained within different amino acid sequence con-et al., 1996). In previous studies, we showed that several
texts of PrPSc.distinct hamster prion strains were indistinguishable by
It should be noted that the conformational stability,Western blotting (Scott et al., 1997). Similarly, in the
indicated by the [GdnHCl]1/2 value, provides one markerpresent study, Western blot analysis of SHa(Sc237) and
of PrPSc structure. Two strains that share [GdnHCl]1/2MH2M(Sc237) PrPSc failed to demonstrate any signifi-
values in the absence of other similar characteristicscant differences, although clear differences in strain
should not necessarily be considered identical. In ourproperties were observed.
studies, both MH2M(Sc237) and MH2M(DY) PrPSc dis-To overcome some of the limitations of one-dimen-
played similar [GdnHCl]1/2 values of 1.0 M. However,sional gel electrophoresis in separating proteins, which
they produced different disease phenotypes in inocu-may differ in the type of their attached glycans, Pan et
lated mice, and the Mr values of their deglycosylated,al. (2001) used two-dimensional (2D) Western blotting
protease-resistant fragments were 21 and 19 kDa, re-to study PrPSc from sporadic CJD (sCJD) and sporadic
spectively. Thus, two phenotypically distinct prions canfatal insomnia (sFI), two forms of human prion disease.
share similar conformational stabilities while main-While conventional Western blotting of these samples
taining different PrPSc conformations.revealed no difference in the susceptibility to protease
digestion and glycoform patterns of PrPSc (Parchi et al.,
2000), 2D immunoblotting analysis disclosed more het- Model for the Species Barrier, Conformational
Change of PrPSc, and Strain Propertieserogeneity in sCJD PrPSc glycoforms than in sFI PrPSc.
It would be of interest to determine whether these human Our results, taken together with previous findings, sug-
gest a model for the species barrier and the emergenceprion strains differ only in glycans attached to PrPSc or
whether differences in conformational properties also of new prion strains. Following transmission of prions
between animals of the same species, incoming PrPScexist. Such studies could be critically important in de-
termining the specific role of glycans in disease phe- interacts directly with PrPC of the host, which leads to
the faithful conversion of PrPC to PrPSc (Prusiner et al.,notype.
We recently described an approach that explores the 1990; Telling et al., 1996). However, passage of PrPSc to
hosts of another species is characterized frequently byconformation of PrPSc by examining its relative confor-
mational stability (Peretz et al., 2001). In this procedure, a prolonged incubation time during the first passage
and relatively shorter and more consistent incubationPrPSc in crude brain fractions is exposed to GdnHCl and
then digested with PK. As the concentration of GdnHCl periods upon subsequent passages. In the present
study, we found that this prolongation, or species barrierincreases, the conformation of PrPSc is destabilized, and
the molecule is rendered susceptible to proteolytic di- effect, is correlated with the emergence of a strain that
differs from the parental prion.gestion. To quantify differences in denaturation profiles,
residual “native” PrPSc was detected using ELISA. Mea- These changes have been attributed to the incoming
prion becoming “adapted” or “selected” in the new spe-surements of the conformational stability of soluble pro-
teins have shown that in order to determine the equilib- cies (Kimberlin and Walker, 1977), which can be ex-
plained by one of two entirely separate ideas: (1) arium constant and the free energy change of unfolding,
G, it is necessary that the unfolding reaction reaches change in the strain identity of the prion was forced, or (2)
the resulting strain was selected from a heterogeneousequilibrium and is reversible. Because conditions for
renaturation of PrPSc have not been identified, the reac- population of strains already existing within the original
inoculum. In the absence of nucleic acid, the strain iden-tion is not reversible, and the G for PrPSc therefore
Conformational Changes of Prion Proteins
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Experimental Procedurestity of a prion lies in its ability to sustain separate infor-
mation states within the same amino acid sequence.
Construction of Tg MiceEach strain, therefore, must maintain different “tem-
The construction of Tg mice with PrP genes has been described
plates” of PrPSc. Applying these ideas to our observa- previously (Scott et al., 1989, 1993, 1997, 1992). The SHa PrP con-
tions, the following scenarios are plausible: (1) the bind- struct corresponds to Syrian hamster PrP (Scott et al., 1989). The
ing of donor PrPSc to nonhomologous PrPC in the host MH2M PrP construct corresponds to mouse PrP with five amino
acid substitutions from SHa PrP at positions 108, 111, 138, 154,provoked the de novo formation of PrPSc that differs
and 169 (Scott et al., 1992). By crossing PrP-ablated mice (Prnp0/0)from the parental PrPSc, and (2) a small subpopulation
with Tg mice, we derived Tg lines that are homozygous for theof PrPSc is preferentially replicated in the new species.
transgene and only express high levels of SHa or MH2M PrPC (Fig-
We presume that the process is inefficient in either sce- ures 1 and 5) (Scott et al., 1997).
nario and thereby leads to the prolonged incubation
period seen upon first passage. Some measure of sup- Scrapie Prion Strains, Inoculations, and Clinical Assessment
port exists for the latter hypothesis: Bartz and col- The Sc237 strain was derived from successive transmissions of
scrapie to sheep, through goats, mice, rats, and finally, to Syrianleagues have shown that a biologically “cloned” hamster
hamsters. The DY strain was established by inoculating brain ho-transmissible mink encephalopathy (TME) isolate could
mogenates from encephalopathic mink into Syrian hamster. Theproduce either the HY or DY prion strain following serial
Sc237 and DY hamster prion strains were a gift of Dr. Richard Marshpropagation, depending on degree of dilution of the
and were repeatedly passaged in golden Syrian hamsters (LVG:Lak)
inoculum (Bartz et al., 2000). purchased from Charles River Laboratory (Wilmington, MA). The
Support for this model arises from the transmission Sc237 strain appears indistinguishable from Syrian hamster strain
of DY prions to Tg(MH2M) mice, in which the nonhomol- 263K in many respects (Kimberlin and Walker, 1977). Syrian ham-
sters and mice were inoculated intracerebrally with 50 l and 30ogous PrPC faithfully replicated the properties from the
l, respectively, of 1% brain homogenate (Scott et al., 1997). Theoriginal SHa(DY) inoculum. Accordingly, the donor and
diagnosis of prion disease and the sacrifice of animals have beenthe recipient animals displayed a similar disease pheno-
previously described (Carlson et al., 1986; Prusiner et al., 1982,
type. Because of this efficient and accurate conversion, 1990).
all transmissions, first and subsequent, resulted in simi-
lar incubation periods. In further support of this model, Preparation of Protein Fraction P2
studies in a cell-free system demonstrated a delay in The P2 protein fraction was prepared as previously described with
slight modifications (Prusiner et al., 1984). In brief, brains were ho-formation of protease-resistant PrP in the presence of
mogenized (10% w/v) in 320 mM sucrose. The homogenate wasnonhomologous PrPC (Horiuchi et al., 2000), and early
centrifuged at 4000  g for 30 min at 4C. To the supernatant, westudies showed that longer incubations in the first pas-
added Triton X-100 and deoxycholic acid (DOC) at detergent:protein
sage are associated with a lower rate of prion accumula- (w:w) ratios of 4:1 and 2:1, respectively, and mixed it for 1 hr at 4C.
tion. Subsequent passages resulted in efficient homolo- To the detergent extract, we added glycerol and polyethylene glycol
gous conversion of PrPC to PrPSc and thus a shorter (PEG) and mixed it for 1 hr at 4C as described (Prusiner et al., 1984).
The PEG precipitate was collected by centrifugation at 10,000  gincubation time.
for 30 min at 4C. The pellet, termed P2 (Prusiner et al., 1984), wasBecause many other strains of prions exist that have
resuspended in 20 mM Tris-OAc (pH 8.3) containing 0.02% Tritonbeen repeatedly passaged in Syrian hamsters and their
X-100 and 1 mM dithiothreitol and adjusted to a protein concentra-resulting PrPSc have been characterized (Peretz et al.,
tion of 8–10 mg/ml.
2001; Safar et al., 1998; Scott et al., 1997), it will be
of considerable interest to corroborate this model by Western Blot Analysis
passaging other strains into Tg(MH2M) mice. An equal volume of 2 sample buffer (Laemmli, 1970) was added
to protein samples. Each SDS-PAGE lane was loaded with 10 g
brain homogenates and 1 g P2 fraction proteins. PrP was detectedNew Approaches to Studying BSE and nvCJD
with the 3F4 anti-PrP monoclonal antibody (mAb) (1g/ml) (KascsakThe study of strains has important practical applications
et al., 1987) and the enhanced chemiluminescence (ECL) detectionrelating to the origin of prion diseases such as BSE
method (Amersham Bioscience, Piscataway, NJ).and nvCJD. The establishment of the conformational
stability assay as an analytical method that explores
HuM-D18
structures of PrPSc, which seem to encipher disease- To improve expression levels of recombinant antibody fragments
specific properties, as well as the construction of Tg (Fabs) against PrP, we cloned the variable region of mouse (Mo)
mice susceptible to human, bovine, and ovine prions Fabs into the plasmid expression vector containing the constant
regions from the human kappa light chain and the CH1 region of thehave opened new approaches to the study of prion
IgG1 heavy chain as described (Carter et al., 1992a). The engineeredstrains. By using these experimental systems in tandem,
polypeptides contain the mouse variable regions from the originalit might be possible to determine whether BSE began
Fab and the constant region of human Fab domains (Carter et al.,with a spontaneous, sporadic case of prion disease in 1992b). Similar to the Mo-Fab polypeptides, chimeric polypeptides
a cow or with the transfer of sheep scrapie to cattle. are secreted separately into the periplasm where light and heavy
The technique might also be applied to determine chain heterodimers are assembled. The new humanized mouse D18
whether the BSE strain of prions, which is pathogenic Fab chimera was termed HuM-D18. We found that compared to
Mo-D18, HuM-D18 had a higher affinity for PrP, which resulted into humans after its propagation in cattle, has infected
greater [GdnHCl]1/2 values for SHa(Sc237) PrPSc. We found that PrPScsheep. Although BSE prions have been used to infect
samples that displayed a [GdnHCl]1/2 value of 1.5 M with Mo-D18sheep experimentally, it is still unknown whether sheep
exhibited a [GdnHCl]1/2 value of 1.8 M when detected with HuM-D18.on farms are propagating the BSE strain of prions and
whether such prions are pathogenic to humans. We be- ELISA Denaturation Transition
lieve that the use of these experimental systems may Aliquots of 10 l from the P2 fraction (10 mg/ml) were mixed with
greatly facilitate our understanding of the molecular ba- an equal volume of GdnHCl stock solutions. GdnHCl stock solutions
were prepared from an 8 M solution (Pierce, Rockford, IL) diluted insis of prion susceptibility.
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water. Following 1 hr of incubation at room temperature, all samples Bessen, R.A., and Marsh, R.F. (1992). Biochemical and physical
properties of the prion protein from two strains of the transmissiblewere diluted with phosphate buffered saline (PBS) containing 2%
Sarkosyl to a final concentration of 0.2 M GdnHCl. Proteinase K mink encephalopathy agent. J. Virol. 66, 2096–2101.
(PK) (Invitrogen, Carlsbad, CA) was added in a ratio of 1:500, i.e., Bessen, R.A., and Marsh, R.F. (1994). Distinct PrP properties sug-
PK:protein (w:w), and digested for 1 hr at 37C. The reaction was gest the molecular basis of strain variation in transmissible mink
stopped with 2 mM phenylmethylsulfonyl fluoride and a cocktail of encephalopathy. J. Virol. 68, 7859–7868.
protease inhibitors (Roche, Indianapolis, IN). Proteins were precipi-
Bruce, M.E., and Dickinson, A.G. (1987). Biological evidence that
tated with 4 volumes of methanol:chloroform (2:1, v:v) for 14 hr
the scrapie agent has an independent genome. J. Gen. Virol. 68,
at 20C. Samples were centrifuged at 4000  g for 30 min at 4C.
79–89.
Pellets were resuspended in 20 l of 6 M GdnSCN solution for 1 hr
Bruce, M.E., and Fraser, H. (1991). Scrapie strain variation and itsand diluted into 0.6 ml of ELISA binding buffer (0.1 M bicarbonate
implications. Curr. Top. Microbiol. Immunol. 172, 125–138.[pH 8.6]). ELISA wells were coated with 50 l of solution containing
Bruce, M., Chree, A., McConnell, I., Foster, J., Pearson, G., and10 g/ml of protein. To further increase the immunoreactivity of
Fraser, H. (1994). Transmission of bovine spongiform encephalopa-PrPSc, coated proteins were denatured in situ with 50 l of 6 M
thy and scrapie to mice: strain variation and the species barrier.GdnSCN. After 10 min at room temperature, the plates were washed
Phil. Trans. R. Soc. Lond. B Biol. Sci. 343, 405–411.three times, blocked, and immunocomplexes of HuM-D18 Fab-PrP
were detected as described (Burton et al., 1991). PK was fully active Bruce, M.E., Will, R.G., Ironside, J.W., McConnell, I., Drummond, D.,
in the presence of 0.2 M GdnHCl, as measured by a colorimetric Suttie, A., McCardle, L., Chree, A., Hope, J., Birkett, C., et al. (1997).
assay with carbobenzoxyvalylglycylarginine p-nitroanilide (Roche). Transmissions to mice indicate that ‘new variant’ CJD is caused by
the BSE agent. Nature 389, 498–501.
Neuropathologic Studies Burton, D.R., Barbas, C.F., III, Persson, M.A., Koenig, S., Chanock,
Immunoperoxidase stain for PrPSc by the hydrolytic autoclaving R.M., and Lerner, R.A. (1991). A large array of human monoclonal
method using the 3F4 mAb was conducted as described (Muramoto antibodies to type 1 human immunodeficiency virus from combina-
et al., 1992). All of the brains were snap-frozen upon dissection from torial libraries of asymptomatic seropositive individuals. Proc. Natl.
the animal and later thawed in room temperature and fixed with Acad. Sci. USA 88, 10134–10137.
10% buffered formalin.
Carlson, G.A., Kingsbury, D.T., Goodman, P.A., Coleman, S., Mar-
shall, S.T., DeArmond, S., Westaway, D., and Prusiner, S.B. (1986).
Data Analysis of ELISA Denaturation Transition Curves Linkage of prion protein and scrapie incubation time genes. Cell 46,
Following addition of the color development substrate p-nitropheny- 503–511.
phosphate, ELISA plates were incubated for 30–90 min at room
Carter, P., Kelley, R.F., Rodrigues, M.L., Snedecor, B., Covarrubias,temperature and absorbance was measured at 405 nm using spec-
M., Velligan, M.D., Wong, W.L., Rowland, A.M., Kotts, C.E., Carver,trophotometer V-max (Molecular Devices, Sunnyvale, CA). The opti-
M.E., et al. (1992a). High level Escherichia coli expression and pro-cal density (OD) patterns were best fitted using the four-parameter
duction of a bivalent humanized antibody fragment. Biotechnologysigmoid algorithm (Maquard-Levendberg algorithm) and the Sig-
10, 163–167.maPlot software (SPSS, Chicago, IL).
Carter, P., Presta, L., Gorman, C.M., Ridgway, J.B., Henner, D.,To plot the remaining fraction of PrPSc as a function of GdnHCl
Wong, W.L., Rowland, A.M., Kotts, C., Carver, M.E., and Shepard,concentration, each measured OD (OD[mean]) within the curve was
H.M. (1992b). Humanization of an anti-p185HER2 antibody for hu-expressed as the apparent fractional extent of native PrPSc, given
man cancer therapy. Proc. Natl. Acad. Sci. USA 89, 4285–4289.that at maximum-fitted OD (OD[max.]), all protease-resistant PrPSc
is present, with a value of 1, and at OD close to zero (OD[min.]), Caughey, B.W., Dong, A., Bhat, K.S., Ernst, D., Hayes, S.F., and
most of PrPSc is denatured and degraded by PK. The following Caughey, W.S. (1991). Secondary structure analysis of the scrapie-
equation was used (Kuwajima, 1995): fractional extent (Fapp) of PK- associated protein PrP 27-30 in water by infrared spectroscopy.
resistant PrPSc 1 (OD[max.]OD[mean])/(OD[max.]OD[min.]). Biochemistry 30, 7672–7680.
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